GlassScriptPhysician profile
Alejandro Barreda Vidal
NPI 1285072553
$463.30
in general payments reported to CMS, 2019-2025
9 companies · $33.77 in 2025
The $33.77 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $14.44 · 2021: $54.11 · 2022: $21.68 · 2023: $121 · 2024: $68.79 · 2025: $33.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $141.89 | 2019-2021 | |
| Cvrx, INC. | $88.17 | 2023-2025 | Barostim Neo System |
| Boston Scientific Corporation | $68.79 | 2024 | Lux-Dx Insertable Cardiac Monitor, Mylux Patient Kit With Mobile Device |
| Pfizer INC. | $48.89 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $45.78 | 2023 | |
| Sanofi-Aventis U.S. LLC | $21.68 | 2022 | |
| Inari Medical, INC. | $20.53 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Chiesi USA, INC. | $14.44 | 2020 | |
| Lilly USA, LLC | $13.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Barreda Vidal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.